Nebenwirkungen · Elocta
ELOCTA 250 IU powder and solvent for solution for injection ELOCTA 500 IU powder and solvent for solution for injection ELOCTA 750 IU powder and solvent for solution for injection ELOCTA 1000 IU powder and solvent for solution for injection ELOCTA 1500 IU powder and solvent for solution for injection ELOCTA 2000 IU powder and solvent for solution for injection ELOCTA 3000 IU powder and solvent for solution for injection ELOCTA 4000 IU powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 6
HOS-133237 · Präparat HOS-097396
Tabulated list of adverse reactions The Table 2 presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level). Frequencies of adverse reactions are based on clinical studies with a total of 379 patients with severe haemophilia A, of which 276 were previously treated patients (PTPs) and 103 were previously untreated patients (PUPs). See section 5.1 for additional details on the clinical studies.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-16T16:13:00Z · SHA-256 3fba66d923efba03310ee5b45c9857060e14279fc6936629efa1aa43943c8a09 · Passage eedbceb16bb49f519b2df78fd186564492e7a7e7f78fb93a832d10269968f1f4 · Zeichen 739–1176 im Abschnitt